Rincon Bio performs MDA-MB-468 xenograft models to test efficacy of preclinical therapies. Please see below for additional information or to request a quote.
MDA-MB-468 cells were isolated from a 51 year old female with adenocarcinoma of the breast
Although the tissue donor was heterozygous for the G6PD alleles, the cell line consistently showed only the G6PD A phenotype. There is a G -> A mutation in codon 273 of the p53 gene resulting in an Arg -> His substitution. EGF receptor is present at 1 X 106 per cell. Ref
Forms tumors in mice
Used in xenografts to test the efficacy of anti-cancer therapeutics
Rincon Bio Growth Curve
MDA-MB-468 cells implanted in NSG mice
WHY WORK WITH
When you work with Rincon Bio, rest assured that all cancer efficacy studies will be performed in the USA, at competitive prices
Most efficacy studies can be initiated within two business days.
We love our clients! We are easy to work with. And we take a personal interest in our clients and their studies.